spacer
home > pmps > winter 2003 > vertical and horizontal integration offers supplier partnerships in drug development and manufacturing
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Vertical and Horizontal Integration Offers Supplier Partnerships in Drug Development and Manufacturing

Pharmaceutical drug development is highly competitive - for the successful companies it can mean billion dollar revenues when a drug hits the market; for the unsuccessful, particularly smaller biotechs with limited pipelines, it can herald complete business failure. Thus pharma companies are looking for every advantage they can gain to shorten timelines, add innovation and drive down costs. This presents a market opportunity to suppliers of this industry, to develop products and services that can really add an edge. The pharma supply industry is in transition from smaller niche players with limited catalogue products, to true partners that provide a single source of supply.

In order to provide the true partnership that industry demands, pharma supply companies must integrate horizontally - by in-house investment and by acquisition to develop the widest possible product offering. The supply company must also develop vertically - to offer 'just in time' product delivery from sophisticated logistics management and distribution, through to high quality manufacturing, not only of in-house products, but also on a bespoke basis to support customers' specific needs as products move up the development chain.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Gerrit van den Dool, Vice President Europe at Sigma-Aldrich Inc

Gerrit van den Dool joined Sigma-Aldrich in 1999 after holding various sales and marketing positions in the life science industry. Since the end of 2002 he has been the Vice President of Sales and Operations in Europe, aligning the company's efforts to improve its customer service.

spacer
Gerrit van den Dool
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

3P Biopharmaceuticals and Nordic Nanovector have extended partnership for Betalutin® late stage manufacturing for B-cell non-Hodgkin lymphoma (NHL) treatment

The non-Hodgkin lymphoma (NHL) is a cancer that starts in white blood cells called lymphocytes, which are part of the body’s immune system
More info >>

White Papers

RSSL introduces same-day mycoplasma testing service in UK

RSSL

Reading Scientific Services Ltd (RSSL), a leading provider of scientific and technical solutions to the global biopharmaceutical, pharmaceutical, and biopharmaceutical sectors, has introduced the United Kingdom’s first same-day mycoplasma testing service for manufacturers of biologic medicines.
More info >>

 
Industry Events

DIA 2019 Global Annual Meeting

23-27 June 2019, San Diego Convention Center

DIA 2019 is more than just a meeting: it’s where brilliant minds come together to create solutions. Thousands of global innovators will convene to engage in discussions on today’s hottest topics in the life sciences field, propose ways to combat daily challenges, and network to create lasting connections.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement